A new survey conducted by talkhealth1, on behalf of Enteromed, shows that stress, rather than food is the main cause of sufferers’ IBS – with 34% saying stress triggered their IBS. And almost 9 out of 10 (88%) said that their IBS stops them socialising at times. When asked about the effectiveness of the treatments they had tried, 86% said they had provided temporary relief, with only 14% saying they had improved their condition. The aim of this survey was to collect the latest data prior to large-scale clinical research on IBS-D and the effectiveness of Enterosgel in its treatment.
It is estimated that up to one in five people in the UK will develop Irritable Bowel Syndrome (IBS) at some stage in their life. IBS can affect sufferers in various ways, with abdominal pain, bloating and bouts of diarrhoea or constipation the most common symptoms. It can be a source of great discomfort, embarrassment and unhappiness, turning holidays and everyday tasks into a struggle.
The IBS Survey for Enterosgel UK was carried out between Tuesday 4th July and Tuesday 15th August 2017. 568 people participated in the survey with 552 fully completing the survey.
Those who were living with IBS were asked to identify the three symptoms that impact them most on a daily basis: stomach pain and discomfort affected 82% (437 people), bloating (75%) and diarrhoea (64%). Over half of those with IBS had been diagnosed by a GP (57%), with 29% being diagnosed by a hospital specialist, and 14% self-diagnosing their IBS.
Stress and food were the causes that most participants felt triggered their IBS; stress 34% and food 28%. Nearly a quarter of people stated that they didn’t know what causes their IBS (22%).
Sufferers were asked to consider how their IBS affects them, by answering yes or no to a series of statements.88% said that ‘my IBS stops me from socialising at times’. Over three quarters of people felt that their IBS stopped them from being effective at work at times and over half had taken time off work due to their IBS. 67% felt that their IBS affected their relationships at home. And 20% had had symptoms that required them to be admitted to hospital due to their IBS.
Participants were asked what treatments they had already tried prior to completing the survey; antispasmodic medicines (40% – 214 people), and probiotics (20%) were the most commonly used. However, when asked about the effectiveness of these treatments, 86% stated that the treatments provided temporary relief and only 14% said that the treatments they had tried had actually improved their condition.
Enterosgel has been available in Europe for more than 20 years, where no systematic side effects have been reported. It is an innovative drug-free intestinal adsorbent that has been introduced to the UK for IBS sufferers three years ago, as an alternative to medications.
Enterosgel is an organic mineral gel proven to adsorb bacterial toxins including E-Coli and C Difficile2. This breakthrough gut treatment tackles the causes of gastrointestinal disorders. It has been scientifically developed to attach or bind to toxins, allergens, pathogens and viruses in the gut. Gut nasties are gently and effectively expelled from the body, helping towards treatment of diarrhoea, allergies and IBS and protection of the intestinal wall.
This oral suspension is free from gluten, sugar and preservatives. It does not take away beneficial substances and is suitable and safe for long–term use and alongside with other treatments.
David Willson comments, “I’ve been using Enterosgel on and off for most of 2016. There are no side-effects at all. It’s not like Imodium, which I don’t like to use, as I don’t think that you should be holding bad things in your body when your body needs to expel them. Enterosgel helps you get rid of them naturally in a gentle way by taking away the bad things as it travels through the body. And it’s even more effective than the silica gel I took.”
Enterosgel® is available over the counter in pharmacies and health stores in 225g tubes, 90g tubes and a box of 10x15g sachets, retailing from £12.80 at pharmacies and health stores, Boots, Lloyds Pharmacy, Holland & Barrett, DayLewis and Superdrug or on-line at enteromed.co.uk.
1 Report for Enterosgel UK, IBS Survey, July – August 2017 conducted by talkhealth Partenrship Ltd
2 Dr Carol Howell, ‘Enterosgel removal of Cdiff toxin B and Endotoxin’, School of Pharmacy & Biomolecular Sciences, University of Brighton, 2017.
Content supplied by Enteromed